NDC 55154-2305-6 - Asacol
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 55154-2305
- Requested NDC
- 55154-2305-6
- Package NDCs from labels
- 55154-2305-6, 55154-2305-4, 55154-2305-8, 55154-2305-2, 55154-2305-0
- Manufacturer
- Cardinal Health
- Effective date
- 2017-10-19
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Asacol - Cardinal Health | Cardinal Health | 2017-10-19 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Socrata Ingredients#
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Mesalamine | MESALAMINE | Ingenus Pharmaceuticals, LLC | 58503afe-b8d4-4710-a194-e3acd64ecf1f | 2026-11-05 | Warnings, Adverse reactions | 4Q81I59GXC |
| Calamine Plus | CALAMINE PLUS PRAMOXINE HCL | AmerisourceBergen Drug Corporation | f161e151-4fab-2fbc-e053-2a95a90a5437 | 2026-11-04 | Warnings | 1K09F3G675 |
| Calamine Plus Pramoxine HCl | CALAMINE PLUS SPRAY | HY-VEE, INC | 415ecfe9-3145-f23e-e063-6394a90adfd8 | 2026-11-04 | Warnings | 1K09F3G675 |
| Calamine Plus | CALAMINE PLUS PRAMOXINE HCL | Meijer Distribution Inc. | 03c46823-0b1f-4101-e063-6294a90aaf94 | 2026-11-04 | Warnings | 1K09F3G675 |
| Calamine Plus Pramoxine HCl | CALAMINE PLUS NO TOUCH SPRAY | Premier Brands of America Inc. | 36481d67-2346-470b-e063-6294a90aae99 | 2026-11-04 | Warnings | 1K09F3G675 |
| Calamine Plus | CALAMINE PLUS PRAMOXINE HCL | Chain Drug Marketing Association Inc | 1a3f8819-58cf-8923-e063-6394a90a37af | 2026-11-04 | Warnings | 1K09F3G675 |
| MESALAMINE | MESALAMINE | KLM Laboratories Private Limited | 54cfed92-5e28-4a4d-a70f-2a60b5b54c12 | 2026-11-03 | Warnings, Adverse reactions | 4Q81I59GXC |
| Mesalamine | MESALAMINE | Aurobindo Pharma Limited | d6c0fc76-644e-4301-9672-f432061e3d37 | 2026-11-02 | Warnings, Adverse reactions | 4Q81I59GXC |
| mesalamine | MESALAMINE | Zydus Pharmaceuticals USA Inc. | 533bfaf5-0add-4b49-a4f2-ddea2b83f65d | 2026-10-27 | Warnings, Adverse reactions | 4Q81I59GXC |
| Lialda | MESALAMINE | Takeda Pharmaceuticals America, Inc. | 3098a080-be86-4265-9818-7fc4beab77b7 | 2026-10-26 | Warnings, Adverse reactions | 4Q81I59GXC |
| Mesalamine | MESALAMINE | Takeda Pharmaceuticals America, Inc. | 4e3b6325-a5bf-4c47-931c-142c0e4d7c3a | 2026-10-23 | Warnings, Adverse reactions | 4Q81I59GXC |
| Clear Eyes Triple Relief | POLYVINYL ALCOHOL AND POVIDONE AND TETRAHYDROZOLINE HYDROCHLORIDE | Prestige Brands Holdings, Inc. | 1269a1a6-843d-4d08-bb3c-c1f3d2e7080d | 2026-10-23 | Warnings | FZ989GH94E |
| Pentasa | MESALAMINE | Takeda Pharmaceuticals America, Inc. | e39d9a3d-5d3a-4bb6-aab1-fdbb2a598606 | 2026-10-23 | Warnings, Adverse reactions | 4Q81I59GXC |
| APRISO | MESALAMINE | Salix Pharmaceuticals, Inc. | 7951139c-b271-45a4-b523-34b23800917b | 2026-10-22 | Warnings, Adverse reactions | 4Q81I59GXC |
| Mesalamine | MESALAMINE | Zydus Pharmaceuticals USA Inc. | cd8493f7-91fd-4c2d-b3d7-c1301825586b | 2026-10-22 | Warnings, Adverse reactions | 4Q81I59GXC |
| Mesalamine | MESALAMINE | Ascend Laboratories, LLC | 43f69db3-81ac-4da4-a61f-fbba6299d9c2 | 2026-10-19 | Warnings, Adverse reactions | 4Q81I59GXC |
| Canasa | MESALAMINE | Allergan, Inc. | 89d91601-152b-4398-bebe-af1c023e9935 | 2026-10-14 | Warnings, Adverse reactions | 4Q81I59GXC |
| Calamine Plus Pramoxine HCl | CALAMINE PLUS SPRAY | Topco Associates LLC | af314adb-bd65-4233-b7e1-6cfb819615a3 | 2026-09-25 | Warnings | 1K09F3G675 |
| Calamine Plus Pramoxine HCl | CALAMINE PLUS NO-TOUCH | Walgreens Company | 33219878-f102-46c6-bd63-e83d54fa2785 | 2026-09-25 | Warnings | 1K09F3G675 |
| Calamine | CALAMINE, PRAMOXIND HCL | Nice-Pak Products, LLC | 9089e23e-ca4a-454f-8dcc-ff5a29a5a335 | 2026-09-22 | Warnings, Adverse reactions | 1K09F3G675 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.